By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies said after the close of the market Wednesday that it will redeem all outstanding 3.25 percent convertible senior notes due 2025 on June 15.

The firm said that as of May 6, there was $350 million in aggregate principal amount of the notes outstanding. The notes are convertible prior to June 14, 5:00 p.m. EDT, at a rate of 20.3560 shares of common stock per $1,000 principal amount of the notes surrendered.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.